Translational molecular imaging and drug development in Parkinson's disease.

Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding We gratefully acknowledge the financial support provided, in part, by NIH grants (MH120197, MH128705, AG063290, AG070060, AG073428, AG074218, AG075444, AG078058, AG079956 and AG080262), Emory Radiology Chair Fund and Emory School of Medicine Endowed Directorship to S.H.L, and the Swiss National Science Foundation AQ7 (Grant number 191836) to A.H."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025